143 related articles for article (PubMed ID: 20167484)
1. The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives.
Bonesi M; Loizzo MR; Statti GA; Michel S; Tillequin F; Menichini F
Bioorg Med Chem Lett; 2010 Mar; 20(6):1990-3. PubMed ID: 20167484
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors.
Kantevari S; Addla D; Bagul PK; Sridhar B; Banerjee SK
Bioorg Med Chem; 2011 Aug; 19(16):4772-81. PubMed ID: 21782455
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
4. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents.
Sivakumar PM; Ganesan S; Veluchamy P; Doble M
Chem Biol Drug Des; 2010 Nov; 76(5):407-11. PubMed ID: 20925692
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines.
Karthikeyan MS; Holla BS; Kumari NS
Eur J Med Chem; 2007 Jan; 42(1):30-6. PubMed ID: 17007964
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
Bandgar BP; Gawande SS; Bodade RG; Gawande NM; Khobragade CN
Bioorg Med Chem; 2009 Dec; 17(24):8168-73. PubMed ID: 19896853
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
Trapani G; Latrofa A; Franco M; Liso G
Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
[TBL] [Abstract][Full Text] [Related]
10. QIGLF, a novel angiotensin I-converting enzyme-inhibitory peptide from egg white protein.
Yu Z; Zhao W; Liu J; Lu J; Chen F
J Sci Food Agric; 2011 Mar; 91(5):921-6. PubMed ID: 21384361
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of proline derivatives as potential angiotensin converting enzyme inhibitor.
Giugliano G; Grieco P; Ialenti A; Mottola M; Perissutti E; Santagada V
Boll Soc Ital Biol Sper; 1996; 72(1-2):29-36. PubMed ID: 8868112
[TBL] [Abstract][Full Text] [Related]
12. Bioguided isolation of angiotensin-converting enzyme inhibitors from the seeds of Plantago asiatica L.
Geng F; Yang L; Chou G; Wang Z
Phytother Res; 2010 Jul; 24(7):1088-94. PubMed ID: 19998322
[TBL] [Abstract][Full Text] [Related]
13. Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
Montes-Avila J; Díaz-Camacho SP; Sicairos-Félix J; Delgado-Vargas F; Rivero IA
Bioorg Med Chem; 2009 Sep; 17(18):6780-5. PubMed ID: 19683930
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure elucidation of five new conjugates of oleanolic acid derivatives and chalcones using 1D and 2D NMR spectroscopy.
Tang C; Zhu L; Li J; Qin R; Liu C; Chen Y; Yang G
Magn Reson Chem; 2012 Mar; 50(3):236-41. PubMed ID: 22383429
[TBL] [Abstract][Full Text] [Related]
15. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
16. Structural requirement of chalcones for the inhibitory activity of interleukin-5.
Yang HM; Shin HR; Cho SH; Bang SC; Song GY; Ju JH; Kim MK; Lee SH; Ryu JC; Kim Y; Jung SH
Bioorg Med Chem; 2007 Jan; 15(1):104-11. PubMed ID: 17064909
[TBL] [Abstract][Full Text] [Related]
17. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, cytotoxicity, and antioxidative activity of minor prenylated chalcones from Humulus lupulus.
Vogel S; Heilmann J
J Nat Prod; 2008 Jul; 71(7):1237-41. PubMed ID: 18611049
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.
Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2011 Jun; 21(12):3755-8. PubMed ID: 21555221
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
